Ex vivo expansion of EPCs derived from human peripheral blood mononuclear cells by Iron-Quercetin complex

© 2017, Scientific Publishers of India. All rights reserved. Cell-based therapy has emerged as a promising new treatment for cardiovascular diseases. One of the main obstacles to this approach is a limited number of endothelial progenitor cells (EPCs) obtained from the patient and lack of an effecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiraporn Kantapan, Songrak Dejphirattanamongkhol, Krai Daowtak, Sittiruk Roytrakul, Padchanee Sangthong, Nathupakorn Dechsupa
Format: Journal
Published: 2018
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017112574&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/56836
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-56836
record_format dspace
spelling th-cmuir.6653943832-568362018-09-05T03:30:54Z Ex vivo expansion of EPCs derived from human peripheral blood mononuclear cells by Iron-Quercetin complex Jiraporn Kantapan Songrak Dejphirattanamongkhol Krai Daowtak Sittiruk Roytrakul Padchanee Sangthong Nathupakorn Dechsupa Biochemistry, Genetics and Molecular Biology © 2017, Scientific Publishers of India. All rights reserved. Cell-based therapy has emerged as a promising new treatment for cardiovascular diseases. One of the main obstacles to this approach is a limited number of endothelial progenitor cells (EPCs) obtained from the patient and lack of an effective culture-expanded techniques. Thus, we aimed to demonstrate the potential use of paramagnetic agent called “IronQ” (complexation of iron and quercetin) to expand progenitor cells derived from peripheral blood mononuclear cells (PBMCs) fraction and evaluate it as cell labeling probe using magnetic resonance imaging (MRI). PBMCs were cultured in the presence of IronQ complex compared to conventional culture medium. After expansion, cells were characterized by immunostaining, tube formation assay, intracellular uptake of IronQ and visualizing of magnetically labeled cells by in vitro MRI. Our data show that IronQ exerted an effective expansion of the cells by maintaining the progenitor content and increasing the population of angiogenic cells. Intracellular uptake of IronQ increased as time dependent and reached the maximum at 153 ± 95 pg IronQ/cells after labeled for 120 h. The labeled cells demonstrated an increase of MRI signal intensity in T1-weighted image when compared to the signal of unlabeled cells. From these data, IronQ complex could promote the conditions that suitable for the growth of endothelial-specific differentiated cells derived from PBMC fraction, after expansion, the magnetically labeled cells can be visualized and localized by MRI. Our study demonstrated that ex vivo expansion of EPCs fractions derived from PBMCs using the paramagnetic agent IronQ complex might be an alternative method for the treatment of cardiovascular disease. 2018-09-05T03:30:54Z 2018-09-05T03:30:54Z 2017-01-01 Journal 0970938X 2-s2.0-85017112574 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017112574&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/56836
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
topic Biochemistry, Genetics and Molecular Biology
spellingShingle Biochemistry, Genetics and Molecular Biology
Jiraporn Kantapan
Songrak Dejphirattanamongkhol
Krai Daowtak
Sittiruk Roytrakul
Padchanee Sangthong
Nathupakorn Dechsupa
Ex vivo expansion of EPCs derived from human peripheral blood mononuclear cells by Iron-Quercetin complex
description © 2017, Scientific Publishers of India. All rights reserved. Cell-based therapy has emerged as a promising new treatment for cardiovascular diseases. One of the main obstacles to this approach is a limited number of endothelial progenitor cells (EPCs) obtained from the patient and lack of an effective culture-expanded techniques. Thus, we aimed to demonstrate the potential use of paramagnetic agent called “IronQ” (complexation of iron and quercetin) to expand progenitor cells derived from peripheral blood mononuclear cells (PBMCs) fraction and evaluate it as cell labeling probe using magnetic resonance imaging (MRI). PBMCs were cultured in the presence of IronQ complex compared to conventional culture medium. After expansion, cells were characterized by immunostaining, tube formation assay, intracellular uptake of IronQ and visualizing of magnetically labeled cells by in vitro MRI. Our data show that IronQ exerted an effective expansion of the cells by maintaining the progenitor content and increasing the population of angiogenic cells. Intracellular uptake of IronQ increased as time dependent and reached the maximum at 153 ± 95 pg IronQ/cells after labeled for 120 h. The labeled cells demonstrated an increase of MRI signal intensity in T1-weighted image when compared to the signal of unlabeled cells. From these data, IronQ complex could promote the conditions that suitable for the growth of endothelial-specific differentiated cells derived from PBMC fraction, after expansion, the magnetically labeled cells can be visualized and localized by MRI. Our study demonstrated that ex vivo expansion of EPCs fractions derived from PBMCs using the paramagnetic agent IronQ complex might be an alternative method for the treatment of cardiovascular disease.
format Journal
author Jiraporn Kantapan
Songrak Dejphirattanamongkhol
Krai Daowtak
Sittiruk Roytrakul
Padchanee Sangthong
Nathupakorn Dechsupa
author_facet Jiraporn Kantapan
Songrak Dejphirattanamongkhol
Krai Daowtak
Sittiruk Roytrakul
Padchanee Sangthong
Nathupakorn Dechsupa
author_sort Jiraporn Kantapan
title Ex vivo expansion of EPCs derived from human peripheral blood mononuclear cells by Iron-Quercetin complex
title_short Ex vivo expansion of EPCs derived from human peripheral blood mononuclear cells by Iron-Quercetin complex
title_full Ex vivo expansion of EPCs derived from human peripheral blood mononuclear cells by Iron-Quercetin complex
title_fullStr Ex vivo expansion of EPCs derived from human peripheral blood mononuclear cells by Iron-Quercetin complex
title_full_unstemmed Ex vivo expansion of EPCs derived from human peripheral blood mononuclear cells by Iron-Quercetin complex
title_sort ex vivo expansion of epcs derived from human peripheral blood mononuclear cells by iron-quercetin complex
publishDate 2018
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017112574&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/56836
_version_ 1681424766423007232